ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

Novartis TO START R&D in Shanghai

November 13, 2006 | APPEARED IN VOLUME 84, ISSUE 46

Novartis will set up a new drug discovery research facility at the Zhangjiang Hi-Tech Park in Shanghai. Employing as many as 400 scientists, it will be among the largest foreign-owned drug discovery centers in China. The company plans to spend $100 million to establish the facility. This money will cover the cost of setting up a temporary R&D center that will begin operating in May 2007 as well as the construction of a more permanent facility with 38,000 m2 of floor space. The firm expects to find most of its scientific staff in the Shanghai area.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment